Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Tailored Implementation: Online ItFits-toolkit in Ireland
Total 0 results
Nothing found
Sponsors and Collaborators
Kyongtae Ty Bae, M.D., Ph.D.
metaMe Health
CEVAC Core Lab, University Ghent
French National Society of Gastroenterology
Seed Health
African Institute for Health and Development
ATTRaCT program by A*STAR BMRC Singapore
Sysmex Inostics GmbH
Bioraba
Intermed Hospital
Klinikum Freising
R.Bos
Menzis
Meyer Children's Hospital, Florence, Italy
Creighton University
Brandeis University
Zhengzhou First People's Hospital
Chul Kim
Chengdu Integrated TCM&Western Medicine Hospital
Jennifer King
View Full List
Medical Conditions
Value-Based Health Insurance
Mild Traumatic Brain Injury; Concussion
Plaque Type Psoriasis
Root Canal Sealers
Adductor Pollicis
Hearing Loss, Bilateral or Unilateral
Regenerative Periodontal Treatment
Bleeding at Gastric Cancer
Systemic Lupus Erythematosus Nephritis
Parenteral Iron Therapy
Alert Fatigue, Health Personnel
Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)
Burn Wound and Skin Graft Healing
Chronic Hepatitis C Virus Infection
Cell Phone Use
Early Phase of Severe Sepsis and Septic Shock
Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
Bacterial Reduction Post-product Application
Failure; Cardiac
View Full List
Drug Interventions
IDP-126 Vehicle Gel
Stem Cell Product
Follitropin beta liquid formulation
Fesoterodine
PF-06650833
0.27 mg/kg, age≥65
Nitric Oxide gas at 160ppm
Galantamine CR
LFG316 active drug
Soy protein isolate
Insulin glargine
Methylphenidate
Estradiol plus MPA
30 mg CVL-231 Target Release, Fed
Itraconazole
Ciclesonide
Bupivacaine 0.5%
Phase 2a, SQY51 (cohort 3)
Esketamine
Leucovorin
View Full List
CROs by country
Contract Research Organizations in Bahamas
Contract Research Organizations in Bahrain
Contract Research Organizations in Brazil
Contract Research Organizations in Cameroon
Contract Research Organizations in Czech Republic
Contract Research Organizations in Kenya
Contract Research Organizations in Liberia
Contract Research Organizations in Malawi
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Paraguay
Contract Research Organizations in Peru
Contract Research Organizations in Tunisia
Contract Research Organizations in Turkmenistan
CRO list by country
CROs in Paraguay
SGS
All CROs in Paraguay
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe